ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

DeVita Asks Panel For Help On Filling Vacancies, Object To “Effort To Get Us Back To 1970 Level”

November 21, 1980

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

March 4, 1983